Exploring uncertainties in melanoma management: a Spanish multidisciplinary Delphi consensus
Clinical and Translational Oncology · 16.10.2026
DOI: 10.1007/s12094-026-04539-7 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Clinical and Translational Oncology, online erschienen am 16.10.2026. Verfasst von Aram Boada und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol-Myers Squibb.
Abstract (Originalsprache)
Purpose
Melanoma is a highly metastatic tumor responsible for 90% of skin cancer deaths. Despite established clinical guidelines, certain areas of its management in Spain remain heterogeneous, particularly in complex scenarios such as neoadjuvant therapy, metastatic sequencing, and follow-up. This project aimed to generate expert-informed recommendations to standardize care in areas of clinical uncertainty. Materials and methods A two-round Delphi process was conducted. Following a systematized review, a multidisciplinary panel of 35 specialists (oncology, dermatology, surgery, and pathology) evaluated 59 statements on uncertain areas of melanoma management. Consensus was defined as ≥ 80% agreement using a 5-point Likert scale.
Results
Overall, 52 statements achieved consensus (3 unanimous, 49 by agreement). Key findings support the use of neoadjuvant immunotherapy in resectable stage III melanoma, particularly in patients with clinically detectable nodal disease, due to its benefit in reducing recurrence risk. A major pathological response was considered a key factor to individualize subsequent surgical and adjuvant decisions. In metastatic disease, therapeutic sequencing algorithms were defined according to BRAF mutational status, prior treatments, and timing of progression. The panel agreed that PD-L1 expression should not be used as the sole factor to exclude patients from anti-PD-1 therapy. Marked variability in follow-up practices was identified, highlighting the need for standardized approaches and quality indicators.
Conclusion
This Delphi consensus reflects the views of a multidisciplinary panel of Spanish melanoma experts on key areas of uncertainty in melanoma management. By integrating evidence and expert experience, the findings may help support clinical decision-making and serve as a complementary reference for clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
- Department of Oncology, Hospital General Universitario, Valencia, Spain.
- Hospital Regional Universitario de Málaga (HRU), Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BioNAND, Universidad de Málaga (UMA), Málaga, Spain.
- Burn Center, Department of Plastic, Cosmetic and Reconstructive Surgery, Hospital Universitario La Paz, Madrid, Spain.
- Service of Oncology, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Oncology, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Förderung
- Bristol-Myers Squibb
Zitieren
APA
Boada, A., Berrocal, A., Berciano-Guerrero, M. Á., Casado, C., Espinosa, E., Márquez-Rodas, I., Nagore, E., Puértolas, T., Rodríguez-Peralto, J. L., Ostios-García, L., Sáez-López, C., & Muñoz-Couselo, E. (2026). Exploring uncertainties in melanoma management: a Spanish multidisciplinary Delphi consensus. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04539-7
Vancouver
Boada A, Berrocal A, Berciano-Guerrero MÁ, Casado C, Espinosa E, Márquez-Rodas I, et al. Exploring uncertainties in melanoma management: a Spanish multidisciplinary Delphi consensus. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04539-7
BibTeX
@article{Boada2026,
author = {Boada, Aram and Berrocal, Alfonso and Berciano-Guerrero, Miguel-Ángel and Casado, César and Espinosa, Enrique and Márquez-Rodas, Iván and Nagore, Eduardo and Puértolas, Teresa and Rodríguez-Peralto, José Luis and Ostios-García, Lorena and Sáez-López, Cristina and Muñoz-Couselo, Eva},
title = {Exploring uncertainties in melanoma management: a Spanish multidisciplinary Delphi consensus},
journal = {Clinical and Translational Oncology},
year = {2026},
doi = {10.1007/s12094-026-04539-7}
}
EUVIMED